Telesurgery: An Audit

Abstract

Since telesurgery is a relatively young medical technology, further longterm study with regard to patient advantages, cost-effectiveness, safety, and clinical applicability is required before the technology can be integrated into the healthcare system. As for standard robotic surgery (not telesurgery), the market is growing worldwide at an average rate of 25% annually, due, in large part, to the approval of new procedures such as single- and multi-vessel, closedchest coronary artery bypass graft(s) (CABG) on a stopped heart, and singleand then multi-vessel closed-chest CABG on a beating heart.